Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids

Biochem J. 1988 Sep 15;254(3):707-14. doi: 10.1042/bj2540707.

Abstract

The biosynthesis of platelet-activating factor (PAF), a phospholipid autocoid with potent ulcerogenic properties that is produced in secretory exocrine glands by physiological secretagogues, was assessed in microsomal preparations of glandular gastric mucosa. For this purpose, 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine (lyso-PAF):acetyl-CoA acetyltransferase (EC 2.3.1.67); the enzymes of the 'de novo' pathway: 1-O-alkyl-2-lyso-sn-glycero-3-phosphate (alkyl-lyso-GP):acetyl-CoA acetyltransferase and 1-O-alkyl-2-acetyl-sn-glycerol (alkylacetyl-G):CDP-choline cholinephosphotransferase (EC 2.7.8.16); and some enzymes involved in the catabolism of PAF and lyso-PAF were assayed. Only the enzymes of the 'de novo' pathway and small amounts of PAF acetylhydrolase, phospholipase A2 and a lysophospholipase D acting on either lipids could be detected in the gastric preparations, whereas lyso-PAF:acetyl-CoA acetyltransferase activity was undetectable. The specific activity of alkyl-lyso-GP:acetyl-CoA acetyltransferase in the gastric mucosa was about one-tenth of that found in spleen microsomes and its apparent Km for acetyl-CoA was 454 microM compared with 277 microM in spleen microsomes. Glandular mucosa homogenates contained preformed PAF at a concentration of 2.7 +/- 0.7 ng equivalents of PAF (hexadecyl)/mg of protein. When gastric microsomes were incubated with micromolar concentrations of fatty acids (arachidonic, palmitic and oleic) prior to the assay of dithiothreitol (DTT)-insensitive cholinephosphotransferase, a dose-dependent reduction in the formation of PAF was observed, arachidonic acid being the most potent inhibitor, followed by linoleic acid (only tested on spleen microsomes) and oleic acid. By contrast, 1,2-diolein and phosphatidylcholine (dipalmitoyl) showed no or little effect. These results indicate that glandular gastric mucosa can produce PAF through the 'de novo' pathway, and that fatty acids, especially unsaturated, can reduce that synthesis by modulating the expression of DTT-insensitive cholinephosphotransferase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Alkyl-2-acetylglycerophosphocholine Esterase
  • Acetyltransferases / metabolism
  • Animals
  • Arachidonic Acid
  • Arachidonic Acids / pharmacology
  • Diacylglycerol Cholinephosphotransferase / antagonists & inhibitors
  • Fatty Acids / pharmacology*
  • Gastric Mucosa / drug effects
  • Gastric Mucosa / metabolism*
  • In Vitro Techniques
  • Kinetics
  • Phosphatidylcholines / pharmacology
  • Phospholipases A / metabolism
  • Phospholipases A2
  • Phosphoric Diester Hydrolases / metabolism
  • Phosphotransferases / metabolism
  • Platelet Activating Factor / biosynthesis*
  • Rats
  • Rats, Inbred Strains

Substances

  • Arachidonic Acids
  • Fatty Acids
  • Phosphatidylcholines
  • Platelet Activating Factor
  • Arachidonic Acid
  • Acetyltransferases
  • acetyl-CoA-1-alkyl-2-lyso-sn-glycero-3-phosphocholine acetyltransferase
  • 1-alkylglycerophosphocholine acetyltransferase
  • Phosphotransferases
  • Diacylglycerol Cholinephosphotransferase
  • Phospholipases A
  • Phospholipases A2
  • 1-Alkyl-2-acetylglycerophosphocholine Esterase
  • Phosphoric Diester Hydrolases
  • alkylglycerophosphoethanolamine phosphodiesterase